224 related articles for article (PubMed ID: 21486729)
41. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.
van der Linden JW; Snelders E; Kampinga GA; Rijnders BJ; Mattsson E; Debets-Ossenkopp YJ; Kuijper EJ; Van Tiel FH; Melchers WJ; Verweij PE
Emerg Infect Dis; 2011 Oct; 17(10):1846-54. PubMed ID: 22000354
[TBL] [Abstract][Full Text] [Related]
42. Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
Mellado E; De La Camara R; Buendía B; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2013 Jan; 30(1):64-8. PubMed ID: 22986228
[TBL] [Abstract][Full Text] [Related]
43. Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA.
Hurst SF; Berkow EL; Stevenson KL; Litvintseva AP; Lockhart SR
J Antimicrob Chemother; 2017 Sep; 72(9):2443-2446. PubMed ID: 28575384
[TBL] [Abstract][Full Text] [Related]
44. Airborne Aspergillus fumigatus spore concentration during demolition of a building on a hospital site, and patient risk determination for invasive aspergillosis including azole resistance.
Wirmann L; Ross B; Reimann O; Steinmann J; Rath PM
J Hosp Infect; 2018 Nov; 100(3):e91-e97. PubMed ID: 30056016
[TBL] [Abstract][Full Text] [Related]
45. Management of chronic pulmonary aspergillosis.
Izumikawa K; Tashiro M; Kohno S
Ann N Y Acad Sci; 2012 Dec; 1272():40-8. PubMed ID: 23231713
[TBL] [Abstract][Full Text] [Related]
46. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
Amorim A; Guedes-Vaz L; Araujo R
Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
[TBL] [Abstract][Full Text] [Related]
47. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
48. Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis.
Seyedmousavi S; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2013 Apr; 57(4):1866-71. PubMed ID: 23380732
[TBL] [Abstract][Full Text] [Related]
49. Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance.
Meneau I; Coste AT; Sanglard D
Med Mycol; 2016 Aug; 54(6):616-27. PubMed ID: 26933209
[TBL] [Abstract][Full Text] [Related]
50. Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.
van der Linden JW; Arendrup MC; Warris A; Lagrou K; Pelloux H; Hauser PM; Chryssanthou E; Mellado E; Kidd SE; Tortorano AM; Dannaoui E; Gaustad P; Baddley JW; Uekötter A; Lass-Flörl C; Klimko N; Moore CB; Denning DW; Pasqualotto AC; Kibbler C; Arikan-Akdagli S; Andes D; Meletiadis J; Naumiuk L; Nucci M; Melchers WJ; Verweij PE
Emerg Infect Dis; 2015 Jun; 21(6):1041-4. PubMed ID: 25988348
[TBL] [Abstract][Full Text] [Related]
51. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.
Meis JF; Chowdhary A; Rhodes JL; Fisher MC; Verweij PE
Philos Trans R Soc Lond B Biol Sci; 2016 Dec; 371(1709):. PubMed ID: 28080986
[TBL] [Abstract][Full Text] [Related]
52. Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
Verweij PE; Chowdhary A; Melchers WJ; Meis JF
Clin Infect Dis; 2016 Feb; 62(3):362-8. PubMed ID: 26486705
[TBL] [Abstract][Full Text] [Related]
53. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.
Mellado E; Garcia-Effron G; Buitrago MJ; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 Jun; 49(6):2536-8. PubMed ID: 15917566
[TBL] [Abstract][Full Text] [Related]
54. Performance of the AsperGenius® PCR assay for detecting azole resistant Aspergillus fumigatus in BAL fluids from allogeneic HSCT recipients: A prospective cohort study from Essen, West Germany.
Pelzer BW; Seufert R; Koldehoff M; Liebregts T; Schmidt D; Buer J; Rath PM; Steinmann J
Med Mycol; 2020 Feb; 58(2):268-271. PubMed ID: 31111913
[TBL] [Abstract][Full Text] [Related]
55. Azole resistance in Aspergillus fumigatus: a growing public health concern.
Vermeulen E; Lagrou K; Verweij PE
Curr Opin Infect Dis; 2013 Dec; 26(6):493-500. PubMed ID: 24126719
[TBL] [Abstract][Full Text] [Related]
56. Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland.
Riat A; Plojoux J; Gindro K; Schrenzel J; Sanglard D
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437612
[No Abstract] [Full Text] [Related]
57. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
[TBL] [Abstract][Full Text] [Related]
58. Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus.
Tetsuka N; Yaguchi T; Machida H; Ito S; Miyairi I
Pediatr Int; 2017 Mar; 59(3):362-363. PubMed ID: 28317305
[No Abstract] [Full Text] [Related]
59. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
Snelders E; van der Lee HA; Kuijpers J; Rijs AJ; Varga J; Samson RA; Mellado E; Donders AR; Melchers WJ; Verweij PE
PLoS Med; 2008 Nov; 5(11):e219. PubMed ID: 18998768
[TBL] [Abstract][Full Text] [Related]
60. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
Howard SJ; Cerar D; Anderson MJ; Albarrag A; Fisher MC; Pasqualotto AC; Laverdiere M; Arendrup MC; Perlin DS; Denning DW
Emerg Infect Dis; 2009 Jul; 15(7):1068-76. PubMed ID: 19624922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
